Comparison of Liver Biomarkers in 288 COVID-19 Patients: A Mono-Centric Study in the Early Phase of Pandemic
Background and Aims: Recent reports have indicated that hepatic dysfunction occurred in a proportion of patients with coronavirus disease 2019 (COVID-19). We aimed to compare and describe the liver biomarkers in different subtypes of COVID-19 patients.Methods: This study enrolled 288 COVID-19 patien...
Main Authors: | Haozhi Fan, Jinyuan Cai, Anran Tian, Yuwen Li, Hui Yuan, Zhengyi Jiang, Yunxi Yu, Lili Ruan, Pingping Hu, Ming Yue, Nian Chen, Jun Li, Chuanlong Zhu |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-01-01
|
Series: | Frontiers in Medicine |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fmed.2020.584888/full |
Similar Items
-
Hepatotropic Properties of SARS-CoV-2—Preliminary Results of Cross-Sectional Observational Study from the First Wave COVID-19 Pandemic
by: Hanna Wiśniewska, et al.
Published: (2021-02-01) -
Clinical application of noninvasive diagnosis of liver fibrosis
by: ZHU Chuanlong
Published: (2015-03-01) -
Overexpression of c-Met in bone marrow mesenchymal stem cells improves their effectiveness in homing and repair of acute liver failure
by: Kun Wang, et al.
Published: (2017-07-01) -
A meta-analysis of the impact of COVID-19 on liver dysfunction
by: Zeng-hong Wu, et al.
Published: (2020-11-01) -
Liver dysfunction associated with hyperthyroidism: Lessons from 2 Case reports
by: Nana Akua Afra Saarah Opoku‐Akyeampong, et al.
Published: (2021-06-01)